QGuideCT (1.0)
Medis Medical Imaging Systems BV · Decision date Oct 5, 2026
What did the FDA decide?
Medis Medical Imaging Systems BV, based in Leiden, Netherlands, received a substantially equivalent (SESE) decision for QGuideCT (1.0) under 510(k) number K260523. FDA recorded the decision on 2026-10-05, with the application received 02/17/2026. The device falls under regulation 892.2050, classified as Automated Radiological Image Processing Software, with primary product code QIH and subsequent product code LLZ; the review panel and medical specialty are both Radiology. This is a 510(k) clearance, not a PMA approval.
The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page shows a statement field but no statement text in the available excerpts. The excerpts do not describe the device's specific components, intended clinical use, or the evidence supporting the equivalence determination; those details would need to come from the underlying FDA documents rather than this summary page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260523
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medis Medical Imaging Systems BV
- Product code
- QIH
- Decision code
- SESE
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated Radiological Image Processing Software.
- Applicant
- Medis Medical Imaging Systems BV
- Product code
- QIH
- FDA device class
- 2
FDA decision timeline
K260523 received
Application receipt date recorded by FDA.
K260523 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Clever OneK260372 | Ewoosoft Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA |
PeekMed webK262667 | Peek Health, S.A. | 510(k) clearance | Nov 4, 2026 | FDA |
CINA-Aneurysm+K262147 | AVICENNA.AI | 510(k) clearance | Oct 19, 2026 | FDA |
Ligence HeartK261733 | UAB Ligence | 510(k) clearance | Oct 7, 2026 | FDA |
NeuroDRK262134 | Deep Reasoning Ai, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medis Medical Imaging Systems BV
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Leiden
Sources and methodology
- Original FDA record: K260523
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


